June 20, 2017 4:50pm
SGMO closes UP +$0.25 to $8.20 and promptly dives -$0.70 or -8.54% to $7.50
SGMO prices 10 M shares at $7.25
Sangamo Therapeutics (SGMO) announced it has commenced an underwritten public offering of shares of its common stock.
SGMO intends to grant the underwriters a 30 day option to purchase up to 15% of the number of shares of common stock to be sold in the offering.
Cowen and Company, LLC and Wells Fargo Securities, LLC are acting as joint book-running managers for the offering.